Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
49.2M
-
Shares change
-
+4M
-
Total reported value, excl. options
-
$2.77B
-
Value change
-
+$223M
-
Put/Call ratio
-
0.93
-
Number of buys
-
61
-
Number of sells
-
-60
-
Price
-
$56.44
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q1 2022
166 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2022.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.2M shares
of 75.6M outstanding shares and own 65.01% of the company stock.
Largest 10 shareholders include FMR LLC (6.05M shares), ORBIMED ADVISORS LLC (6.03M shares), Bain Capital Life Sciences Investors, LLC (4.83M shares), PERCEPTIVE ADVISORS LLC (4.53M shares), VANGUARD GROUP INC (2.88M shares), BlackRock Inc. (2.3M shares), BOXER CAPITAL, LLC (2.08M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.88M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.84M shares), and BANK OF AMERICA CORP /DE/ (1.63M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.